ABUS Operating Income Growth
Arbutus Biopharma Corp · Operating Income Growth
ABUS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported314.78%period ending
ABUS TTM Operating Income YoY % (-1222.39% → 314.78%)
Year-over-year change
High-resolution chart · PNG
ABUS operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 314.779% | |
| 268.8257% | |
| 35.6556% | |
| 33.3646% | |
| 17.6671% | |
| -14.4417% | |
| 2.2842% | |
| -4.0229% | |
| -9.2949% | |
| -11.3471% | |
| -19.3214% | |
| -25.4797% | |
| -18.4859% | |
| -4.4682% | |
| 10.9709% | |
| 7.7318% | |
| 2.3528% | |
| -14.0631% | |
| -27.1875% | |
| -26.5622% | |
| 49.6374% | |
| 56.31% | |
| 59.8631% | |
| 63.1212% | |
| -47.0213% | |
| -52.6856% | |
| -60.4166% | |
| -11.0902% | |
| 21.7277% | |
| 18.5435% | |
| 19.0661% | |
| 56.7941% | |
| 63.8454% | |
| 77.3378% | |
| 77.4367% | |
| -25.2734% | |
| -10.1981% | |
| -369.8829% | |
| -380.5761% | |
| -142.8232% | |
| -470.2762% | |
| -131.6148% | |
| -210.2693% | |
| -310.4684% | |
| -132.7691% | |
| -198.8926% | |
| -171.7154% | |
| -58.4658% | |
| -56.4662% | |
| -13.5864% | |
| 5.7211% | |
| -68.7556% | |
| -51.7346% | |
| -29.3842% | |
| -19.4724% | |
| 41.3771% | |
| 18.0634% | |
| 8.9269% | |
| 13.6801% | |
| -102.8123% | |
| 16.7371% | |
| -0.2167% | |
| -45.3981% | |
| 10.2014% | |
| -49.4726% | |
| 7.0033% | |
| 23.1518% | |
| -1.3213% | |
| -109.7706% | |
| -1,222.3874% |